COLON CANCER
Clinical trials for COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new COLON CANCER trials appear
Sign up with your email to follow new studies for COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer pill tested in advanced tumors – study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called ATX-559 in 17 people with advanced solid tumors (like breast, colon, or endometrial cancer) that had stopped responding to standard treatments. The main goal was to find a safe dose and understand side effects. The st…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control TerminatedThis study tested a new treatment for people with certain cancers (pancreatic, colon, stomach, rectal) that have a specific genetic change called KRAS G12D. Doctors took white blood cells from each patient, modified them in a lab to better recognize and attack cancer cells, and t…
Matched conditions: COLON CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors like lung, stomach, bladder, kidney, colon, or esophageal cancer that had come back. The main goals were to find a safe dose and check for side effects. The study was stopped early, so …
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New cancer drug tested in people with advanced tumors
Disease control TerminatedThis early study tested a new drug called PHN-010 in 26 people with advanced cancers like lung, colon, and ovarian cancer. The drug is designed to deliver a powerful treatment directly to cancer cells. The main goals were to check safety and find the right dose, but the study was…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC